Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction

Mounting clinical and preclinical evidence supports a key role for sustained adrenergic signaling in the tumor microenvironment as a driver of tumor growth and progression. However, the mechanisms by which adrenergic neurotransmitters are delivered to the tumor microenvironment are not well understo...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Vol. 78; no. 12; p. 3233
Main Authors: Allen, Julie K, Armaiz-Pena, Guillermo N, Nagaraja, Archana S, Sadaoui, Nouara C, Ortiz, Tatiana, Dood, Robert, Ozcan, Merve, Herder, Danielle M, Haemmerle, Monika, Gharpure, Kshipra M, Rupaimoole, Rajesha, Previs, Rebecca A, Wu, Sherry Y, Pradeep, Sunila, Xu, Xiaoyun, Han, Hee Dong, Zand, Behrouz, Dalton, Heather J, Taylor, Morgan, Hu, Wei, Bottsford-Miller, Justin, Moreno-Smith, Myrthala, Kang, Yu, Mangala, Lingegowda S, Rodriguez-Aguayo, Cristian, Sehgal, Vasudha, Spaeth, Erika L, Ram, Prahlad T, Wong, Stephen T C, Marini, Frank C, Lopez-Berestein, Gabriel, Cole, Steve W, Lutgendorf, Susan K, De Biasi, Mariella, Sood, Anil K
Format: Journal Article
Language:English
Published: United States 15.06.2018
ISSN:1538-7445, 1538-7445
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mounting clinical and preclinical evidence supports a key role for sustained adrenergic signaling in the tumor microenvironment as a driver of tumor growth and progression. However, the mechanisms by which adrenergic neurotransmitters are delivered to the tumor microenvironment are not well understood. Here we present evidence for a feed-forward loop whereby adrenergic signaling leads to increased tumoral innervation. In response to catecholamines, tumor cells produced brain-derived neurotrophic factor (BDNF) in an ADRB3/cAMP/Epac/JNK-dependent manner. Elevated BDNF levels in the tumor microenvironment increased innervation by signaling through host neurotrophic receptor tyrosine kinase 2 receptors. In patients with cancer, high tumor nerve counts were significantly associated with increased BDNF and norepinephrine levels and decreased overall survival. Collectively, these data describe a novel pathway for tumor innervation, with resultant biological and clinical implications. Sustained adrenergic signaling promotes tumor growth and metastasis through BDNF-mediated tumoral innervation. .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:1538-7445
1538-7445
DOI:10.1158/0008-5472.CAN-16-1701